| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |